SALVI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 7.202
EU - Europa 5.430
AS - Asia 4.544
SA - Sud America 874
Continente sconosciuto - Info sul continente non disponibili 287
AF - Africa 95
OC - Oceania 14
AN - Antartide 1
Totale 18.447
Nazione #
US - Stati Uniti d'America 6.998
CN - Cina 1.492
SG - Singapore 1.463
PL - Polonia 1.415
DE - Germania 1.034
IT - Italia 729
BR - Brasile 718
UA - Ucraina 669
HK - Hong Kong 372
FI - Finlandia 349
VN - Vietnam 347
FR - Francia 308
GB - Regno Unito 271
IN - India 249
RU - Federazione Russa 237
TR - Turchia 163
BD - Bangladesh 143
CA - Canada 112
IE - Irlanda 109
SE - Svezia 89
ID - Indonesia 71
AR - Argentina 57
MX - Messico 50
BE - Belgio 48
NL - Olanda 39
JP - Giappone 33
IQ - Iraq 30
AT - Austria 29
ZA - Sudafrica 28
ES - Italia 25
EC - Ecuador 24
RO - Romania 22
SA - Arabia Saudita 20
CO - Colombia 19
EU - Europa 17
PK - Pakistan 17
PY - Paraguay 15
AE - Emirati Arabi Uniti 13
AU - Australia 13
JM - Giamaica 13
JO - Giordania 13
KE - Kenya 13
IR - Iran 12
VE - Venezuela 12
CL - Cile 11
KR - Corea 11
CZ - Repubblica Ceca 10
MA - Marocco 10
OM - Oman 10
UZ - Uzbekistan 10
LT - Lituania 9
NG - Nigeria 9
TH - Thailandia 9
CR - Costa Rica 8
AZ - Azerbaigian 7
BO - Bolivia 6
EG - Egitto 6
IL - Israele 6
KZ - Kazakistan 6
MU - Mauritius 6
MY - Malesia 6
PH - Filippine 6
TN - Tunisia 6
UY - Uruguay 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
LY - Libia 5
PE - Perù 5
AL - Albania 4
GR - Grecia 4
RS - Serbia 4
AM - Armenia 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
DM - Dominica 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NP - Nepal 3
TW - Taiwan 3
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RE - Reunion 2
SD - Sudan 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 18.156
Città #
Warsaw 1.411
Singapore 789
Ashburn 575
Jacksonville 456
San Jose 402
Fairfield 378
Hong Kong 365
Chandler 361
Beijing 325
Woodbridge 311
Ann Arbor 276
The Dalles 274
New York 235
Council Bluffs 232
Helsinki 226
Brescia 219
Houston 216
Princeton 196
Wilmington 184
Los Angeles 182
Nanjing 169
Cambridge 164
Seattle 143
Lauterbourg 122
Istanbul 113
Columbus 110
Dublin 109
Ho Chi Minh City 105
Munich 104
Buffalo 96
Chicago 92
Dallas 91
Dearborn 87
Des Moines 80
Milan 74
Dong Ket 70
São Paulo 68
Santa Clara 66
Shanghai 58
San Francisco 57
Changsha 56
Orem 54
Nanchang 53
Shenyang 50
Hanoi 49
Jakarta 46
Jinan 46
Moscow 46
Brussels 45
Hebei 42
Lancaster 41
Tianjin 39
Redondo Beach 38
Pune 37
Jiaxing 32
Toronto 31
Brooklyn 30
Phoenix 28
San Diego 27
Tokyo 27
Turku 27
Lappeenranta 26
Mexico City 26
Boardman 25
Kunming 25
Rio de Janeiro 25
Salt Lake City 25
Kocaeli 24
Montreal 24
Guangzhou 23
Rome 23
Atlanta 22
Chennai 22
Hangzhou 21
Nuremberg 21
Frankfurt am Main 20
Amsterdam 19
Denver 19
London 19
Boston 18
North York 18
Nürnberg 18
Charlotte 17
Johannesburg 17
Mumbai 17
Verona 17
Zhengzhou 17
Manchester 16
Ningbo 16
Tampa 16
Vienna 15
Da Nang 14
Poplar 14
Amman 13
Belo Horizonte 13
Stockholm 13
Curitiba 12
Romola 12
Bari 11
Nairobi 11
Totale 11.159
Nome #
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 358
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 355
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 354
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 324
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 294
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 277
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 268
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 262
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 256
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 238
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 233
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 230
Functional Role of microRNA-23b-3p in Cancer Biology 224
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 224
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 220
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 212
Biological Function of MicroRNA193a-3p in Health and Disease 208
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 208
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 196
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 192
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 192
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 190
microRNAs and human hepatocellular carcinoma 184
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 184
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 183
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 180
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 176
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 174
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 173
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 171
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 170
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 167
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 167
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 167
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 161
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 160
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 157
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 154
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 154
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 153
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 153
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 152
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 152
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 151
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 150
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 142
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 141
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 139
Urokinase and c-met are target of miR-23b in human cells. 137
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 137
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 137
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 137
DNA methylation variations in familial female and male breast cancer 137
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 135
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 134
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 131
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 130
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 129
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 128
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 128
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 128
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 126
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 126
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 123
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 123
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 122
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 122
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 122
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 121
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 119
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 119
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 118
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 117
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 116
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 116
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 116
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 115
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 114
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 113
Determination of longitudinal Circulating levels of miR-21-5p, miR-23b-3p and miR-34a-5p in plasma of patients with glioblastoma using droplet digital PCR 112
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 112
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 112
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 111
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 111
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 109
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 109
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 108
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 106
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 106
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 106
Dysregulation of a Subset of Circulating and Vesicle-Associated miRNA in Pancreatic Cancer. 105
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 105
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 104
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 104
Lasp1 expression is implicated in embryonic development of zebrafish 102
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 101
The enrichment of miR-23b-3p, miR-126-3p and GAS5 in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the tumor growth of xenografts in zebrafish model 100
RNA interference for urokinase gene in human hepatocellular carcinoma 100
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 99
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 97
Totale 15.825
Categoria #
all - tutte 76.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022644 0 0 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/20252.739 37 50 49 384 216 240 199 74 332 144 663 351
2025/20265.330 475 668 379 744 527 464 719 213 336 488 204 113
2026/2027737 247 236 254 0 0 0 0 0 0 0 0 0
Totale 18.447